These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2525415)

  • 1. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
    Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC; Stagg RJ; Friedman MA; Hannigan JF; Rayner A; Ignoffo RJ; Acord P; Lewis BJ
    J Clin Oncol; 1989 Nov; 7(11):1646-54. PubMed ID: 2530317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.
    Lorenz M; Hottenrott C; Inglis R; Kirkowa-Reimann M
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3662-71. PubMed ID: 2531992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
    Hohn DC; Rayner AA; Economou JS; Ignoffo RJ; Lewis BJ; Stagg RJ
    Cancer; 1986 Feb; 57(3):465-70. PubMed ID: 2935242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ
    Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.
    Kemeny N; Daly J; Reichman B; Geller N; Botet J; Oderman P
    Ann Intern Med; 1987 Oct; 107(4):459-65. PubMed ID: 2957943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
    Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
    Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma.
    Kemeny N; Cohen A; Bertino JR; Sigurdson ER; Botet J; Oderman P
    Cancer; 1990 Jun; 65(11):2446-50. PubMed ID: 2140070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
    Kemeny N; Conti JA; Sigurdson E; Cohen A; Seiter K; Lincer R; Niedzwiecki D; Botet J; Chapman D; Costa P
    Cancer; 1993 Mar; 71(6):1964-71. PubMed ID: 8443746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulation with leucovorin.
    Lorenz M; Hottenrott C; Maier P; Reimann M; Inglis R; Encke A
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):163-70. PubMed ID: 1532672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of locoregional chemotherapy in patients with liver metastases from colorectal primaries.
    Lorenz M; Heinrich S; Staib-Sebler E; Gog C; Vetter G; Petrowsky H; Müller HH
    Swiss Surg; 2000; 6(1):11-22. PubMed ID: 10709432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M; Müller HH
    J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
    Rougier P; Laplanche A; Huguier M; Hay JM; Ollivier JM; Escat J; Salmon R; Julien M; Roullet Audy JC; Gallot D
    J Clin Oncol; 1992 Jul; 10(7):1112-8. PubMed ID: 1296590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.
    Chang AE; Schneider PD; Sugarbaker PH; Simpson C; Culnane M; Steinberg SM
    Ann Surg; 1987 Dec; 206(6):685-93. PubMed ID: 2961314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ; Boddie AW; Charnsangavej C; Ajani JA; Wallace S; Soski M; Claghorn L; Mavligit GM
    J Clin Oncol; 1986 Sep; 4(9):1356-64. PubMed ID: 2943876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
    Kemeny N; Seiter K; Niedzwiecki D; Chapman D; Sigurdson E; Cohen A; Botet J; Oderman P; Murray P
    Cancer; 1992 Jan; 69(2):327-34. PubMed ID: 1303612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant regional chemotherapy after resection of liver metastases of primary colorectal tumors].
    Lorenz M; Hottenrott C; Encke A
    Zentralbl Chir; 1993; 118(5):279-89. PubMed ID: 8322538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
    Patt YZ; Mavligit GM; Chuang VP; Wallace S; Johnston S; Benjamin RS; Valdivieso M; Hersh EM
    Cancer; 1980 Jul; 46(2):261-5. PubMed ID: 6446376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.